TABLE 1.
Processing method
|
Source,a y
|
Approximate sensitivity or LoD
|
Sample type
|
65°C for 30 min | L'Helgouach et al. 2020 | 73% Sensitivity at qPCR Ct < 35. | Saliva |
95°C for 15 min | Alekseenko et al. 2021 | Sensitivity comparable to qPCR at Ct = 20–25 | NP swabs |
95°C for 5 min | Thi et al. 2020 | Sensitivity comparable to qPCR at Ct = 25–30 | NP swabs |
Chelex-100, DTT | Howson et al 2020 | Sensitivity comparable to qPCR at Ct = 25–30 | Saliva |
Chelex-100 | Flynn et al. 2020 | 100 copies/μL | Saliva |
Proteinase K | Ben-Assa et al. 2020 | Sensitivity comparable to qPCR at Ct = 28 | NP swabs in UTM, saliva |
Proteinase K | Azmi et al. 2020* | 10 copies/reaction | Saliva |
Proteinase K (QuickExtract) | Joung et al. 2020* | 100 copies/reaction | NP swab in VTM |
Proteinase K (QuickExtract) | Nguyen et al. 2020* | 1 copy/μL | NP swabs |
Semialkaline proteinase | Yamazaki et al. 2021 | 170–230 copies/μL | Saliva |
TCEP/EDTA (Quick Extract) | Agrawal et al. 2021* | 40 copies/μL | Saliva |
TCEP/EDTA or DTT/EDTA | Rabe and Cepko 2020 | 50 copies/μL | Saliva, NP swabs |
TCEP/EDTA | Sherrill-Mix et al. 2021a and 2021b | 100 copies/μL | Saliva |
TCEP, proteinase K | Yang et al. 2021 | 200 copies/μL | Saliva |
TCEP, RNASecure, proteinase K | Lalli et al. 2021 | 25 copies/μL | Saliva |
Thermolabile proteinase K | Wei et al. 2020 | 2.5 copies/μL | NP swabs in VTM |
Abbreviations: Ct, cycle threshold; DTT, dithiothreitol; LAMP, loop-mediated isothermal amplification; LoD, limit of detection; qPCR, quantitative polymerase chain reaction; TCEP, tris(2-carboxyethyl)phosphine; UTM, universal transport medium; VTM, viral transport medium.
Asterisks (*) indicate sensitivity reported using a combination reverse transcription–LAMP/recombinase polymerase amplification (RT-LAMP/RPA) with CRISPR-Cas detection; otherwise, only RT-LAMP was used.